2026 Life Sciences Market Sentiment Report
New avenues for growth amid global uncertainty.
Based on insights from senior life sciences leaders, this report explores how organisations are responding to uncertainty — and where they are identifying opportunities to adapt, invest, and grow in 2026.
What the findings show
Life sciences organisations are making high‑stakes decisions in a volatile environment. The findings highlight how leaders are navigating pressure on funding, skills, data, and collaboration — and where priorities are shifting for the year ahead.
In this report, you’ll see:
- Where leaders plan to invest, hold, or cut back in 2026
- How organisations are using data and AI to guide research decisions
- What’s shifting in partnership models and collaboration
- Where confidence is growing — and where concerns remain
Why it matters now
Life sciences organisations are making decisions today that will shape research outcomes for years to come. Understanding how peers are responding to uncertainty helps teams act with confidence — not assumption.
Use these insights to:
- Benchmark your plans against global life sciences decision‑makers
- Anticipate emerging risks and inflection points
- Support internal conversations with independent evidence
From the foreword
“What emerges is a balanced picture: one of renewed optimism tempered by realism, and of organisations recalibrating to build resilience and long‑term advantage.”